Medical Equipment Import Company

Request for study

Mashroo3k Consulting offers a comprehensive feasibility study for a medical device import company in Egypt, designed to ensure maximum profitability and the best possible payback period. This is achieved through in-depth market size analysis, strategic assessment of both local and international competitors, and the development of competitive pricing proposals.

Capital

Rate of return

Recovery period The second year

Medical devices are among the high-demand commodities in Egypt’s healthcare sector, according to data from Mashroo3k Consulting regarding the supply and demand trends in the Egyptian medical equipment market.<br>Establishing a medical device import company in Egypt is considered a promising investment opportunity, targeting private clinics, specialized hospitals, and various healthcare sectors.<br>Mashroo3k Consulting offers investors specialized feasibility studies for launching a medical equipment import company in Egypt. These studies are based on updated and reliable market data specific to the Egyptian healthcare landscape, helping ensure the project’s success, maximize profitability, and achieve an optimal payback period.<br>

Project products

Cavitation + lipo laser slimming machine MED-280
Vela shape MED-360
lipo laser + fractional RF MED-350
q switched ND yag laser MED-810A
CO2 fractional laser MED-870
vertical HIFU Ulift
Oxygen jet peel machine MED-370

Why Mashroo3k ?

Mashroo3k has over 11 years of experience in preparing feasibility studies, conducting market research, and providing comprehensive consulting services.
Mashroo3k has offices in 7 international branches, located in Saudi Arabia, the UAE, Egypt, Qatar, Oman, Yemen, and Iraq, in addition to its agents in China, Singapore, and other countries.
Having delivered over 7,000 feasibility studies, Mashroo3k has helped thousands of clients achieve their investment goals.
Mashroo3k’s services are accredited and trusted by all financial institutions and funding entities across the Middle East.
The company’s geographic reach spans 35 countries across all continents.
Mashroo3k holds membership in over 100 prestigious international organizations specializing in market research and business management.
Its team consists of 350 consultants with deep expertise in promising economic sectors, ensuring tailored solutions and strategies that meet clients’ needs.
Mashroo3k is partnered with more than 10,200 suppliers across 22 countries, providing logistical support for projects, including production lines, raw materials, machinery, and equipment.
With an extensive database, Mashroo3k enhances the accuracy of its forecasts and analyses, strengthening its risk management capabilities.

Products that meet international quality standards.
Implementation of general transport and storage regulations.
A management team with ambitious plans.

Executive summary

About the project
Financial indicators
Justifications for establishing the project
Government investment incentives in the project field
Target markets
Indicators and final results of the project

Study project services/products

Project Description and All Its Products/Services.
Project Advantages and Production Requirements.

Market Size Analysis

Understanding Distribution Channels.
Consumer Behavior, Preferences, and Habits.
Competitors’ Products or Services, and Their Strengths and Weaknesses.
Market Nature and Characteristics.
Demand Size for the Product or Service Offered.
Available Market Share of the Target Market.
The Optimal Marketing Method.

Risk Assessment

Risk Identification.
Impact of Risks on the Project.
Risk Mitigation Methods

Technical study

A detailed description of the project’s products, expected production capacity, and determination of investment costs.
Determining the required electricity and water capacity.
Determining the project’s labor requirements.
Determining the project’s requirements.
Calculating construction and building costs.
Calculating the total capital
Determining the annual operating costs.
Determining the amount of working capital.

Financial study

Total investment costs required for the project.
Organizing cash flow statements, income statements, and the balance sheet for the first ten years of operation.
Determine the expected annual revenues of the project in light of the specified operational capacities
The optimal financing structure for the project in light of investors’ capabilities and financing conditions.
The project’s financial indicators and sensitivity analysis.

Organizational and administrative study

Project workforce.
Organizational structure.
Job responsibilities.

The Healthcare Sector in GCC Countries
Key Indicators and Insights from Mashroo3k Consulting for Investors

Mashroo3k Consulting presents a set of vital indicators and key insights for anyone looking to invest in the healthcare sector and its projects across the GCC countries:

The total number of hospitals in the GCC stands at 802, according to the latest statistics. The public sector accounts for 58.9%, while the private sector represents 41.1% of the total.
Over 61% of general physicians are based in Saudi Arabia.
The UAE recorded the highest percentage of private sector physicians among GCC countries, at 64%, followed by Bahrain at 44.8%, and Qatar at 27.1%.
Kuwait has the highest percentage of government sector physicians at 79%, followed by Oman at 74.6% and Saudi Arabia at 71.6%.
In Saudi Arabia, annual spending on digital health infrastructure is expected to rise from $0.5 billion to $1.5 billion by 2030.
The GCC region currently has around 700 healthcare projects at various stages of development, valued at approximately $60.9 billion. These include hospitals, clinics, and research centers, with 264 projects worth $24.7 billion currently under construction.

Over the years, Mashroo3k has developed a deep belief in the critical role the healthcare sector plays in driving economic growth and uplifting nations. Rooted in this conviction, the company shares additional insights for those interested in investing in healthcare projects within the GCC:

Healthcare spending in the GCC is projected to reach $104.6 billion by 2022, up from $76.1 billion in 2017.
Average healthcare inflation across the GCC is expected to decline to 4% in the coming years.
Due to the anticipated increase in patient numbers, GCC countries will require a hospital bed capacity of approximately 118,295 beds.
Artificial Intelligence (AI) is forecasted to represent 30% of hospital investments in the GCC between 2023 and the end of 2030.
The pharmaceutical manufacturing market in the GCC is expected to grow to a value between $8 billion and $10 billion.
The medical consumables manufacturing sector is projected to flourish between 2025 and 2030, with an expected market size of $30 billion.

Global Healthcare Sector: A Strategic Investment Opportunity

According to United Nations reports, the global population is expected to reach 8.5 billion by 2030 and approximately 9.7 billion by 2050. This surge in population will inevitably lead to increased demand for healthcare services. Therefore, Mashroo3k strongly recommends investing in this vital sector.

Global health expenditure is anticipated to grow at an annual rate of 3.9% between 2020 and 2024—significantly higher than the 2.8% growth rate recorded between 2015 and 2019.

It is worth noting that, globally, there are only 2.9 hospital beds per 1,000 people, and 1.8 physicians per 1,000 people. Meanwhile, the number of nurses and midwives stands at 4 per 1,000 people. These figures fall well below the actual need, highlighting the pressing demand for increased investment in the healthcare sector.

Technological advancements have played a pivotal role in improving healthcare services worldwide. Over the past decade, survival rates and quality of life have improved significantly. Experts forecast that the global healthcare services market will grow from USD 6,872.86 billion in 2021 to USD 7,548.52 billion by the end of 2022. By 2026, the market is expected to reach USD 10,414.36 billion, with a compound annual growth rate (CAGR) of 8.4% over the forecast period (2022–2026).